Evidence map›Paper›PMID 34445150›Full record

ArticleInternational journal of molecular sciences2021

Freeze-Dried Secretome (Lyosecretome) from Mesenchymal Stem/Stromal Cells Promotes the Osteoinductive and Osteoconductive Properties of Titanium Cages.

Elia Bari, Fulvio Tartara, Fabio Cofano, Giuseppe di Perna, Diego Garbossa, Sara Perteghella, Marzio Sorlini, Delia Mandracchia, Lorella Giovannelli, Paolo Gaetani and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. MSC-Exos: Important active factor of bone regeneration.Frontiers in bioengineering and biotechnology · 2023
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Elia BariDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.ORCID 0000-0003-0241-0620
Fulvio TartaraFondazione IRCCS Istituto Neurologico Nazionale Mondino, Via Mondino 2, 27100 Pavia, Italy.
Fabio CofanoNeuroscience Department, "Rita Levi Montalcini", Via Cherasco 15, 10126 Torino, Italy.
Giuseppe di PernaNeuroscience Department, "Rita Levi Montalcini", Via Cherasco 15, 10126 Torino, Italy.ORCID 0000-0002-7381-9194
Diego GarbossaNeuroscience Department, "Rita Levi Montalcini", Via Cherasco 15, 10126 Torino, Italy.
Sara PerteghellaDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.ORCID 0000-0003-1128-7636
Marzio SorliniPharmaExceed S.r.l., Piazza Castello 19, 27100 Pavia, Italy.
Delia MandracchiaDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy.ORCID 0000-0002-7101-013X
Lorella GiovannelliDepartment of Pharmaceutical Sciences, University of Piemonte Orientale, Largo Donegani 2/3, 28100 Novara, Italy.ORCID 0000-0002-6422-341X
Paolo GaetaniPharmaExceed S.r.l., Piazza Castello 19, 27100 Pavia, Italy.
Maria Luisa TorreDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.ORCID 0000-0001-8062-6836
Lorena SegaleDepartment of Pharmaceutical Sciences, University of Piemonte Orientale, Largo Donegani 2/3, 28100 Novara, Italy.ORCID 0000-0003-2331-4339
University of Pavia · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITFondazione Istituto Neurologico Nazionale Casimiro Mondino · ITOspedale Humanitas Gradenigo · ITUniversity of Applied Sciences and Arts of Southern Switzerland · CHUniversity of Brescia · IT

Funding

Interreg V-A Italy-Switzerland 2014-2020 ATEx-Advanced Therapies Experiences. Project ID 637541
6 · The paper itself

Abstract

Titanium is one of the most frequently used materials in bone regeneration due to its good biocompatibility, excellent mechanical properties, and great osteogenic performance. However, osseointegration with host tissue is often not definite, which may cause implant failure at times. The present study investigates the capacity of the mesenchymal stem cell (MSC)-secretome, formulated as a ready-to-use and freeze-dried medicinal product (the Lyosecretome), to promote the osteoinductive and osteoconductive properties of titanium cages. In vitro tests were conducted using adipose tissue-derived MSCs seeded on titanium cages with or without Lyosecretome. After 14 days, in the presence of Lyosecretome, significant cell proliferation improvement was observed. Scanning electron microscopy revealed the cytocompatibility of titanium cages: the seeded MSCs showed a spread morphology and an initial formation of filopodia. After 7 days, in the presence of Lyosecretome, more frequent and complex cellular processes forming bridges across the porous surface of the scaffold were revealed. Also, after 14 and 28 days of culturing in osteogenic medium, the amount of mineralized matrix detected by alizarin red was significantly higher when Lyosecretome was used. Finally, improved osteogenesis with Lyosecretome was confirmed by confocal analysis after 28 and 56 days of treatment, and demonstrating the production by osteoblast-differentiated MSCs of osteocalcin, a specific bone matrix protein.

Indexed as

Bone RegenerationBone SubstitutesCell ProliferationCells, CulturedFreeze DryingHumansMesenchymal Stem CellsOsteogenesisTissue ScaffoldsTitaniumBone SubstitutesTitaniumbone regenerationmesenchymal stem cells (MSCs)MSC-extracellular vesiclesMSC-secretome

Identifiers

PMID34445150
PMCPMC8395097
OpenAlexW3190749561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.